SWTX:NSD-SpringWorks Therapeutics Inc (USD)

COMMON STOCK | Biotechnology |

Last Closing

USD 41.2

Change

+0.13 (+0.32)%

Market Cap

N/A

Volume

1.02M

Analyst Target

USD 54.40
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-08-28 )

Largest Industry Peers for Biotechnology

Symbol Name Price(Change) Market Cap
REGN Regeneron Pharmaceuticals Inc

-11.11 (-0.95%)

USD 130.01B
VRTX Vertex Pharmaceuticals Inc

+6.72 (+1.40%)

USD 123.52B
ALNY Alnylam Pharmaceuticals Inc

+3.54 (+1.35%)

USD 33.60B
ARGX argenx NV ADR

+2.24 (+0.42%)

USD 32.41B
MRNA Moderna Inc

-1.40 (-2.01%)

USD 28.23B
BGNE BeiGene Ltd

+2.22 (+1.13%)

USD 20.54B
BMRN Biomarin Pharmaceutical Inc

+0.52 (+0.62%)

USD 17.44B
RPRX Royalty Pharma Plc

+0.17 (+0.62%)

USD 17.14B
UTHR United Therapeutics Corporatio..

-1.99 (-0.58%)

USD 15.72B
PCVX Vaxcyte Inc

+1.87 (+1.64%)

USD 14.27B

ETFs Containing SWTX

HFIN:CA Hamilton Enhanced Canadia.. 10.17 % 0.00 %

+0.05 (+0.28%)

CAD 0.15B
CEW:CA iShares Equal Weight Banc.. 9.71 % 0.60 %

+0.12 (+0.28%)

CAD 0.21B
FLI:CA CI U.S. & Canada Lifeco C.. 8.86 % 0.92 %

+0.05 (+0.28%)

CAD 0.09B
HEF:CA 7.65 % 0.83 %

N/A

N/A
HPR:CA Global X Active Preferred.. 1.80 % 0.63 %

-0.01 (0.28%)

CAD 1.05B
DXM:CA 0.00 % 0.67 %

N/A

N/A
PR:CA Lysander-Slater Preferred.. 0.00 % 1.03 %

+0.01 (+0.28%)

CAD 0.08B
RODM Hartford Multifactor Deve.. 0.00 % 0.31 %

+0.02 (+0.28%)

N/A
XMD:CA iShares S&P/TSX Completio.. 0.00 % 0.61 %

+0.35 (+0.28%)

CAD 0.20B
BANK:CA Evolve Canadian Banks and.. 0.00 % 0.39 %

+0.04 (+0.28%)

CAD 0.23B
BNC:CA 0.00 % 0.68 %

N/A

N/A
TQCD:CA TD Q Canadian Dividend ET.. 0.00 % 0.00 %

+0.10 (+0.28%)

CAD 0.38B

Market Performance

  Market Performance vs. Industry/Classification (Biotechnology) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.88% 69% C- 74% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.88% 69% C- 72% C
Trailing 12 Months  
Capital Gain 42.66% 79% B- 87% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 42.66% 79% B- 86% B+
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 26.92% 76% C+ 82% B
Dividend Return 26.92% 76% C+ 82% B
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 77.42% 41% F 22% F
Risk Adjusted Return 34.77% 87% B+ 67% D+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector